Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of th...
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
About this item
Full title
Author / Creator
Hochhaus, Andreas , Gambacorti-Passerini, Carlo , Abboud, Camille , Gjertsen, Bjørn Tore , Brümmendorf, Tim H. , Smith, B. Douglas , Ernst, Thomas , Giraldo-Castellano, Pilar , Olsson-Strömberg, Ulla , Saussele, Susanne , Bardy-Bouxin, Nathalie , Viqueira, Andrea , Leip, Eric , Russell-Smith, T. Alexander , Leone, Jocelyn , Rosti, Gianantonio , Watts, Justin , Giles, Francis J. , on behalf of the BYOND Study Investigators and BYOND Study Investigators
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Bosutinib is approved for newly diagnosed Philadelphia chromosome-positive (Ph+) chronic phase (CP) chronic myeloid leukemia (CML) and for Ph+ CP, accelerated (AP), or blast (BP) phase CML after prior treatment with tyrosine kinase inhibitors (TKIs). In the ongoing phase 4 BYOND study (NCT02228382), 163 CML patients resistant/intolerant to prior TK...
Alternative Titles
Full title
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Authors, Artists and Contributors
Author / Creator
Gambacorti-Passerini, Carlo
Abboud, Camille
Gjertsen, Bjørn Tore
Brümmendorf, Tim H.
Smith, B. Douglas
Ernst, Thomas
Giraldo-Castellano, Pilar
Olsson-Strömberg, Ulla
Saussele, Susanne
Bardy-Bouxin, Nathalie
Viqueira, Andrea
Leip, Eric
Russell-Smith, T. Alexander
Leone, Jocelyn
Rosti, Gianantonio
Watts, Justin
Giles, Francis J.
on behalf of the BYOND Study Investigators
BYOND Study Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_uu_439516
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_439516
Other Identifiers
ISSN
0887-6924,1476-5551
E-ISSN
1476-5551
DOI
10.1038/s41375-020-0915-9
